Concomitant Proton Pump Inhibitors With Mycophenolate Mofetil and the Risk of Rejection in Kidney Transplant Recipients

Hypomagnesemia Induced by Several Proton-Pump Inhibitors

(2013) Maarten A.C. Broeren   ANNALS OF INTERNAL MEDICINE

Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry

(2012) Anthony Langone et al.   CLINICAL TRANSPLANTATION

Mycophenolic Acid Pharmacokinetics During Maintenance Immunosuppression in African American and Caucasian Renal Transplant Recipients

(2011) Kathleen M. Tornatore et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers

(2011) M. G. Kees et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The proton pump inhibitor pantoprazole and its interaction with enteric-coated mycophenolate sodium in transplant recipients

(2011) Sieglinde Kofler et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

The Role of Proton Pump Inhibitors on Early Mycophenolic Acid Exposure in Kidney Transplantation: Evidence From the CLEAR Study

(2011) Bryce A Kiberd et al.   THERAPEUTIC DRUG MONITORING

Mycophenolic Acid Dose Reductions Result in Poor Long-Term Renal Allograft Survival: Comparison Between Mycophenolate Sodium and Mycophenolate Mofetil

(2011) M.R. Laftavi et al.   TRANSPLANTATION PROCEEDINGS

A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia

(2010) Ewout J. Hoorn et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Impact of gastrointestinal-related side effects on mycophenolate mofetil dosing and potential therapeutic strategies

(2010) Suphamai Bunnapradist et al.   CLINICAL TRANSPLANTATION

Proton pump inhibitors interfere with the immunosuppressive potency of mycophenolate mofetil

(2010) M. Schaier et al.   RHEUMATOLOGY

A Systematic Review of the Effect of CYP3A5 Genotype on the Apparent Oral Clearance of Tacrolimus in Renal Transplant Recipients

(2010) Arden Barry et al.   THERAPEUTIC DRUG MONITORING

Proton Pump Inhibitor Co-medication Reduces Active Drug Exposure in Heart Transplant Recipients Receiving Mycophenolate Mofetil

(2010) A.O. Doesch et al.   TRANSPLANTATION PROCEEDINGS

Proton Pump Inhibitors Reduce Mycophenolate Exposure in Heart Transplant Recipients-A Prospective Case-Controlled Study

(2009) S. Kofler et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Mycophenolic Acid Exposure after Administration of Mycophenolate Mofetil in the Presence and Absence of Ciclosporin in Renal Transplant Recipients

(2009) Dirk R. Kuypers et al.   CLINICAL PHARMACOKINETICS

African American Kidney Transplantation Survival

(2009) Gregory E. Malat et al.   DRUGS

Bioavailability of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium Is Differentially Affected by Pantoprazole in Healthy Volunteers

(2009) Korbinian Rupprecht et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Proton Pump Inhibitor Co-medication Reduces Mycophenolate Acid Drug Exposure in Heart Transplant Recipients

(2009) Sieglinde Kofler et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Influence of Lansoprazole and Rabeprazole on Mycophenolic Acid Pharmacokinetics One Year After Renal Transplantation

(2009) Masatomo Miura et al.   THERAPEUTIC DRUG MONITORING

Influence of Immunosuppressive Regimens on Graft Survival and Secondary Outcomes After Kidney Transplantation

(2009) Gerhard Opelz et al.   TRANSPLANTATION

Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review

(2009) Simon R. Knight et al.   TRANSPLANTATION